-
公开(公告)号:EP3554577B1
公开(公告)日:2024-08-07
申请号:EP17828682.9
申请日:2017-12-14
CPC分类号: A61M1/16 , A61M1/1698 , A61M1/34 , A61M1/342 , A61M1/3496 , A61M1/3621 , A61M1/3666 , A61M1/3679 , A61M2205/1220130101 , A61M2205/333420130101 , A61M2205/333720130101 , A61M1/3434 , A61M1/3603 , A61M1/36225
-
2.
公开(公告)号:EP3554578B1
公开(公告)日:2024-08-07
申请号:EP17828684.5
申请日:2017-12-14
CPC分类号: A61M1/16 , A61M1/1698 , A61M1/34 , A61M1/342 , A61M1/3496 , A61M1/3621 , A61M1/3666 , A61M1/3679 , A61M2205/1220130101 , A61M2205/333420130101 , A61M2205/333720130101 , A61M1/3434 , A61M1/3603 , A61M1/36225
-
公开(公告)号:EP4395665A1
公开(公告)日:2024-07-10
申请号:EP22778149.9
申请日:2022-09-06
申请人: Biolife, LLC
IPC分类号: A61B17/135 , A61B17/00 , A61M5/31
-
4.
公开(公告)号:EP3222300B1
公开(公告)日:2024-06-26
申请号:EP17159742.0
申请日:2007-09-19
CPC分类号: A61M2205/338220130101 , A61M2205/338920130101 , A61M2205/332720130101 , A61M2205/333720130101 , A61N1/0468 , A61N5/0616 , A61N2005/066120130101 , G01F23/14 , A61M1/73 , A61M1/74 , A61M1/732 , A61M1/982 , A61M1/962 , A61M1/60 , A61M1/743
-
-
公开(公告)号:EP4037742B1
公开(公告)日:2024-04-17
申请号:EP20781470.8
申请日:2020-09-25
CPC分类号: A61M16/0075 , A61M16/0057 , A61M16/0051 , A61M16/0072 , A61M16/0066 , A61M16/201 , A61M2205/333720130101 , A61M2205/333420130101 , A61M2205/336820130101 , A61M2230/0620130101 , A61M2230/3020130101 , A61M2230/5020130101 , A61M2230/4220130101 , A61M2230/00520130101 , A61M2230/6320130101 , A61M16/04 , A61M16/06 , A61M2205/50520130101 , A61M2205/5220130101 , A61M2205/355320130101 , A61M2205/356120130101
-
7.
公开(公告)号:EP4039302B1
公开(公告)日:2024-10-09
申请号:EP22150582.9
申请日:2022-01-07
CPC分类号: A61M16/024 , A61M16/1075 , A61M16/1045 , A61M16/0084 , A61M16/06 , A61M2016/002720130101 , A61M2016/003920130101 , A61M16/204 , A61M16/208 , A61M16/122 , A61M2202/028320130101 , A61M2202/020820130101 , A61M16/1005 , A61M2205/1520130101 , A61M2205/820620130101 , A61M2240/0020130101 , A61M2205/50220130101 , A61M2205/1820130101 , A61M2205/021620130101 , A61M2205/50520130101 , A61M2205/58320130101 , A61M16/1055 , A61M16/1065 , A61M2205/333720130101 , A61M2205/334120130101 , A61M2205/334420130101
-
公开(公告)号:EP4436630A2
公开(公告)日:2024-10-02
申请号:EP22834792.8
申请日:2022-11-17
申请人: Carefusion 303 Inc.
发明人: NGUYEN, Vincent Vinh , PUTHUKKAD, Rahul Rajan , KRISHNAN, Abhishek , DESAI, Aman , SUMAN, Kaushik , PEDDI, Srinivas Ramakrishnarao , RAJPAL, Sumit
CPC分类号: A61M5/142 , A61M5/1411 , A61M5/1424 , A61M2205/333720130101 , A61M2205/07820130101 , A61M3/0262
-
公开(公告)号:EP3701920B1
公开(公告)日:2024-06-05
申请号:EP19211581.4
申请日:2016-04-26
-
10.
公开(公告)号:EP4368218A1
公开(公告)日:2024-05-15
申请号:EP22206048.5
申请日:2022-11-08
申请人: Haermonics BV
CPC分类号: A61M2210/10120130101 , A61M2205/3620130101 , A61M2205/333720130101 , A61M2205/330620130101 , A61M2205/338620130101 , A61M2205/338220130101 , A61M2205/333420130101 , A61M1/79 , A61M3/0283
摘要: The invention provides a flushing system (1, 200, 300, 400, 500) configured to flush a wound and/or a body cavity, in particular the pericardial cavity (PC), of a patient, wherein the system (1, 200, 300, 400, 500) comprises: an infusion liquid outlet (2) to connect a first tube (4) having an infusion liquid lumen to guide a flow of infusion liquid from the system (1, 200, 300, 400, 500) to the wound and/or the body cavity, in particular the pericardial cavity (PC), an effusion liquid inlet (6) to connect to a second tube (8) having an effusion liquid lumen to guide the effusion liquid flow from the wound and/or the body cavity, in particular the pericardial cavity (PC), to the system (1, 200, 300, 400, 500), a buffer container (10) having a buffer volume and comprising a buffer inlet (12) to receive effusion liquid from the wound and/or the body cavity, in particular the pericardial cavity (PC), and a first buffer outlet (14) to output the received effusion liquid, a flow rate control system to control the flow rate of the effusion liquid output from the buffer container (10), wherein the flow rate control system comprises: a control unit (16) to provide one or more control signals, a first pump device (18) for pumping effusion liquid from the buffer container (10) to one or more effusion liquid container (20) at an effusion liquid flow rate, wherein the effusion liquid flow rate is adjustable by the control signals of the control unit (16), wherein the buffer container (10) comprises a clot trap (22) configured for preventing clots included in the effusion liquid being received from the wound and/or the body cavity, in particular the pericardial cavity (PC), from exiting the buffer container (10) via the first buffer outlet (14), and/or wherein the buffer container (10) is configured for air-liquid-separation, and/or configured with a safety bypass, and/or configured for receiving liquid gushes.
-
-
-
-
-
-
-
-
-